Teva issues multi-tranche notes worth $3.2B and €1.5B
Teva completed a multi-currency senior unsecured notes offering totaling $3.2 billion and €1.5 billion to refinance debt and enhance financial flexibility.
Teva completed a multi-currency, multi-tranche senior unsecured notes offering totaling $3.2 billion and €1.5 billion, with the proceeds earmarked to refinance debt and improve financial flexibility. The five series include €1.0 billion of 4.250% notes due 2033 and €500 million of 4.625% notes due 2036 issued by Teva Pharmaceutical.